Seroprevalence of SARS-CoV-2 among the staff and patients of a French cancer centre after first lockdown: The canSEROcov study.

Fiche publication

Date publication

février 2021

Journal

European journal of cancer (Oxford, England : 1990)

Auteurs

Membres identifiés du Cancéropôle Est :
Dr ARNOULD Laurent , Dr BERTAUT Aurélie , Dr COUDERT Bruno , Pr COUTANT Charles , Pr GHIRINGHELLI François , Dr LADOIRE Sylvain , Mme TRUNTZER Caroline , Dr VINCENT Julie , Dr HERVIEU Alice , Dr FAVIER Laure , Dr BENGRINE-LEFEVRE Leila , Dr DESMOULINS Isabelle , Dr FUMET Jean-David , Dr HENNEQUIN Audrey , Dr ZANETTA Sylvie , Dr MAYEUR Didier , Dr GOUSSOT Vincent

Tous les auteurs :
Ladoire S, Goussot V, Redersdorff E, Cueff A, Ballot E, Truntzer C, Ayati S, Bengrine-Lefevre L, Bremaud N, Coudert B, Desmoulins I, Favier L, Fraisse C, Fumet JD, Hanu R, Hennequin A, Hervieu A, Ilie S, Kaderbhai C, Lagrange A, Martin N, Mazilu I, Mayeur D, Palmier R, Simonet-Lamm AL, Vincent J, Zanetta S, Arnould L, Coutant C, Bertaut A, Ghiringhelli F

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/33780664

Résumé

In view of the potential gravity of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection for patients with cancer, epidemiological data are vital to assess virus circulation among patients and staff of cancer centres. We performed a prospective study to investigate seroprevalence of SARS-CoV-2 antibodies among staff and patients with cancer at a large cancer centre, at the end of the period of first national lockdown in France and to determine factors associated with the risk of SARS-CoV-2 infection.